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Adopting a family approach to theory and practice: measuring
distress in cancer patient-partner dyads with the distress
thermometer
Abstract
Objective: Significant others are central to patients' experience and management of their cancer illness.
Building on our validation of the Distress Thermometer (DT) for family members, this investigation
examines individual and collective distress in a sample of cancer patients and their matched partners,
accounting for the aspects of gender and role.Method: Questionnaires including the DT were completed
by a heterogeneous sample of 224 couples taking part in a multisite study.Results: Our investigation
showed that male patients (34.2%), female patients (31.9%), and male partners (29.1%) exhibited very
similar levels of distress, while female partners (50.5%) exhibited much higher levels of distress
according to the DT. At the dyad level just over half the total sample contained at least one individual
reporting significant levels of distress. Among dyads with at least one distressed person, the proportion
of dyads where both individuals reported distress was greatest (23.6%). Gender and role analyses
revealed that males and females were not equally distributed among the four categories of dyads (i.e.
dyads with no distress; dyads where solely the patient or dyads where solely the partner is distressed;
dyads where both are distressed).Conclusion: A remarkable number of dyads reported distress in one or
both partners. Diverse patterns of distress within dyads suggest varying risks of psychosocial strain.
Screening patients' partners in addition to patients themselves may enable earlier identification of risk
settings. The support offered to either member of such dyads should account for their role- and
gender-specific needs. Copyright © 2010 John Wiley & Sons, Ltd.
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Abstract 
 
Objective: Significant others are central to patients’ experience and management of 
their cancer illness. Building on our validation of the Distress Thermometer (DT) for 
family members, the present investigation examines individual and collective distress in a 
sample of cancer patients and their matched partners, accounting for the aspects of gender 
and role. 
Method: Questionnaires including the DT were completed by a heterogeneous 
sample of 224 couples taking part in a multi-site study. 
Results: Our investigation showed that male patients (34.2%), female patients 
(31.9%), and male partners (29.1%) exhibited very similar levels of distress, while female 
partners (50.5%) exhibited much higher levels of distress according to the DT. At the dyad 
level just over half the total sample contained at least one individual reporting significant 
levels of distress. Among dyads with at least one distressed person, the proportion of dyads 
where both individuals reported distress was greatest (23.6%). Gender and role analyses 
revealed that males and females were not equally distributed among the four categories of 
dyads (i.e., dyads with no distress; dyads where solely the patient or dyads where solely the 
partner is distressed; dyads where both are distressed). 
Conclusion: A remarkable number of dyads reported distress in one or both 
partners. Diverse patterns of distress within dyads suggest varying risks of psychosocial 
strain. Screening patients’ partners in addition to patients themselves may enable earlier 
identification of risk settings. The support offered to either member of such dyads should 
account for their role- and gender-specific needs. 
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INTRODUCTION 
The cancer illness of a family member presents an endurance test for the entire 
family unit [1]. If patients’ family members adopt active, supportive roles, it can have a 
positive effect on patients’ experience of their illness [2-4]. Study results have also shown, 
however, that emotionally burdened family members can hinder patients’ adjustment to 
their illness [5,6]. Though psycho-oncology researchers have increasingly given attention 
to the family context of cancer, it is still not common to focus on family distress in clinical 
settings.  
Stress Factors in the Family Context 
Cancer can turn an entire family system upside down, causing upheaval in the organization 
of everyday life, in the distribution of roles within the family and between partners, and can 
disrupt future plans [7,8]. Spouses, in particular, often find themselves negotiating a new 
role related to their partner’s cancer experience while simultaneously attempting to retain a 
sense of stability and consistency [9]. Role changes through the introduction of serious 
illness frequently presents additional challenges within the family, or between partners, and 
they may temporarily alter relationships by decreasing closeness, intimacy, reciprocity [10] 
and possibly sexual activity [11,12]. Changes in relationships and distress can trigger 
conflicts within couples or families and further exacerbate existential fears, uncertainties, 
and suffering that cancer may introduce. For instance, in many cases, a new experience of 
difficulty in communication may arise between trusting family members, causing further 
complications as familiar family interactions change [13]. These and other consequences of 
cancer may lead to the transmission of distress through many interrelated channels in the 
family system; transmission of distress may be particularly strong in the patient partner 
system [14,15]. 
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Recognizing Psychological Distress 
While issues regarding psychosocial care of family members of patients in cancer 
clinics is well researched, the practical application of our knowledge, toward effective, 
regular assessment and care for family members, remains an unrealized goal [1,16]. One 
central barrier to progress in this area is that patients (and their medical experience), as 
opposed to their partners, are the focus of cancer care and hence have a greater chance of 
receiving referrals for supportive services. Family members of cancer patients report of 
receiving little support from outsiders, specialists [17], and from patients themselves 
[18,19]. Significant others often remain in the background while attention is focused on the 
patient; in one qualitative study, a male spouse reported his “liminal” experience of being 
the partner of a woman with breast cancer [9]. Indeed, family members find it difficult, and 
often experience feelings of guilt, when requesting help and support for themselves [20,21]. 
A common consequence of this is that family members’ psychiatric and psychosocial 
symptoms and needs go unnoticed by medical staff. This phenomenon has been reported by 
several researchers in connection with patients themselves: the task of identifying patients 
who suffer psychological distress and are likely to require related care is complicated; 
corresponding rates of recognition among medical professionals have been shown to be 
poor [22-26]. Thus far, no similar studies of the prevalence of assessing or identifying 
family members’ distress have been undertaken.  
Scope of Psychological Distress and Screening for Distress 
A critical minority of cancer patients and their family members experience high 
levels of psychological distress. Reported levels of distress vary significantly due to 
differing conceptualizations, diverse criteria for distress, differences in methodological 
approaches to measurement, and variety in research populations [27]. Hodges’ [15] meta-
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analysis comprising 21 studies has indicated that partners are just as likely as patients to 
experience distress concurrent with a cancer diagnosis. In a recent meta-analysis by 
Hagedoorn [28], particular attention was given to gender effects. The study revealed that 
individual levels of distress were determined more by gender than by patient-partner role: 
women consistently reported more distress than their male counterparts, regardless of their 
role as patient or partner. Estimates are high regarding the number of cancer patients and 
family members who do not fulfill the formal criteria for a psychological disorder 
according to the ICD or DSM but do suffer from clinically relevant psychosocial distress 
[13,29,30]. The psycho-oncology community has responded to the increasing awareness of 
high distress levels in many populations of cancer patients by establishing routine 
psychosocial screening programs as a part of cancer care.  
In our own recent investigation, we validated the Distress Thermometer (DT) for 
use in screening cancer patients’ family members for clinically significant distress in the 
form of symptoms of depression and anxiety. Building on our validation of the DT, the 
investigation described below reports the results of using the DT to clinically assess 
distress among a sample of patient-partner dyads. We sought to quantify individual and 
collective distress in cancer patients and their partners accounting for the aspects of gender 
and role.  Research in this area suggests that women, regardless of their role as patient or 
partner, will report higher levels of distress than men. 
 
METHOD 
The methods of this investigation have already been published elsewhere in detail 
[31]. The current report was derived from a larger report for the Zurich Cancer League. 
Data used in the current report stem from a multi-site study that included four oncology 
units in the region of Zurich, Switzerland.  
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Procedure 
Patients were identified on the basis of scheduled outpatient oncology visits at one 
of the participating sites between July 1st and December 31st, 2005. Based on the advice of 
clinic staff who reviewed the patient lists, individuals were identified and excluded from 
participation who were not in sufficient command of the German language or were 
considered too weak or incapacitated to complete the questionnaire and thus unable to 
provide reliable, valid responses. No exclusion criteria were applied with respect to the 
specific location of patients’ cancer or the stage of their illness.  
Patients identified as eligible for study participation were contacted by mail. They 
were asked to complete a questionnaire and to distribute a similar questionnaire to the 
person they considered their closest family member during the course of their illness. 
Patients and family members were provided with separate postage-paid envelopes and 
asked to fill out their respective questionnaires separately. 
Participants  
A total of 1,234 patients were contacted by mail, resulting in an overall response 
rate of 38.6%, based on a response rate of 42.6% (526) among patients and 34.6% (427) 
among family members. Forty-four family members’ questionnaires were excluded [31]; 
while nine patient questionnaires were excluded due to imprecise responses. 
Individuals who declined to participate were asked to return answers to a brief set 
of questions regarding the reason(s) for their refusal: 74 patients and 62 family members 
responded to these questions. The top two reasons cited for opting out of participation 
were: (1) that filling out the questionnaire would be too distressing or exhausting (33 
patients; 28 family members); and, (2) that providing personal statements was undesirable 
(16 patients; 14 family members). No further information was requested from individuals 
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who declined to participate. The final number of completed questionnaires included in the 
analyses was 764 (30.9%), comprising 443 (35.8%) patient and 321 (26%) family 
members. 
The present investigation examined effects of gender and role on distress in 
couples. Thus, analyses were limited to heterosexual patients and their partners. Other 
family members who returned responses (a total of 96 adult siblings, adult children, other 
close family members) and one homosexual couple were excluded. The total number of 
people included in the final analyses was 448 (224 questionnaires filled out by patients; 
224 filled out by their matched spouse or partner). All study documents were approved by 
the ethics commission of the Zurich university hospital and by the institutions participating 
in the study.   
Measures 
Distress Thermometer (DT). Subjective distress in patients and family members was 
assessed using the Distress Thermometer developed by Roth and colleagues [32]. 
Individuals were asked to rate how distressed they felt in the previous week on a single-
item scale from zero (not distressed) to ten (extremely distressed). In order to distinguish 
two categories – “healthy” and “sick” – using a screening test, it is necessary to establish a 
threshold score (usually called a “cut-off”). For the sake of clarity, we chose to use a two-
number figure as a cut-off score, such as 4/5, indicating that the threshold lies between 
these two numbers. Such notation avoids the ambiguity that can arise when using a single 
number (e.g., “a cut-off of 8 was used”). We utilized the original version of the DT without 
including the problem list suggested by the NCCN Clinical Practice Guidelines for Distress 
Management for cancer patients, as a considerable portion of that list is dedicated to 
various physical complaints associated with cancer or its treatment. 
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The NCCN Guidelines [33] currently recommend a cut-off score of 3/4 when 
assessing patients. This case rule was lowered from 4/5 to 3/4 in 2007. When assessing 
partners, we opted to apply the previous higher case rule of 4/5. This case rule showed 
more promise in maximizing appropriate detection rates when compared to the Hospital 
Anxiety and Depression Scale (HADS) in our recent validation of the DT with family 
members of cancer patients [31].  
 Demographic variables. Patients and partners reported their age and gender, 
education level, civil status (married, not married), years of partnership, whether 
patients are cohabiting with their partner or not, and their household income.  
Medical variables. Medical information was derived from patient self-reports 
and included: the location and type of patients’ cancer (cancer site). A broad range of 
cancer diagnoses were represented, with some patients suffering from more than one 
cancer type. Diagnostic groups bearing fewer than 7 patients in total (e.g., those with 
diagnoses of ovarian cancer, pancreatic cancer, stomach cancer, prostate cancer) were 
included in the category “other.”; treatments undergone since diagnosis (applied 
cancer treatment and number of treatments undergone) and actual treatment status 
(in or off treatment of the first diagnosis; in or off treatment of a relapse or new 
diagnosis; cured; palliative stage; status as unknown to patient); time elapsed since 
diagnosis refers to the number of months that passed between the date of a patient’s most 
recent diagnosis and the date his or her data were collected for the study.  
Last but not least “subjective physical well-being” was assessed with a visual 
analogue scale from 0 to 10. Patients rated their average level of “physical well-being” 
in the last two weeks.  
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Statistics. Statistical analyses were conducted using ‘R’[34]. Patients’ and partners’ 
mean DT scores and the frequency distribution of the DT were reported to facilitate 
comparison between these groups and with other samples. In addition, analyses of variance 
and correlations were employed to examine the association of several important illness-
specific variables (type of cancer; treatment status; time elapsed since last diagnosis) with 
distress.  
For the sake of classification, patients and their partners were matched and assigned 
to one of four groups according to their DT scores. The groups were used to distinguish 
dyads with zero (Quadrant 1; patient low-partner low), one (Quadrants 2; patient low-
partner high and 3; patient high-partner low), or two individuals suffering clinically 
significant levels of distress (Quadrant 4; patient high-partner high). Chi-square tests were 
used to differentiate the groups according to gender and role (patient vs. partner). Our 
sample consisted solely of mixed gender patient-partner dyads. Thus, the variables of role 
and gender are dependent on one another. For instance, if the number of female patients is 
low in one quadrant, then the number of their male partners in that same quadrant must also 
be low. Moreover, the remaining female patients must be distributed between the other 
three quadrants. Therefore, a significant result in one quadrant produces significant 
variation between quadrants. Hence, it was unnecessary to perform individual post-hoc 
tests. 
 
RESULTS 
Descriptive data are shown in Table 1.  
 (Table 1) 
Description of distress among and between patients and their partners 
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Initially, Distress Thermometer (DT) scores were analyzed separately for male and 
female patients and their partners. The mean DT score for male patients was 3.20 (SD = 
2.53; 1st Qu. = 1; median = 2; 3rd Qu. = 5), while the mean DT score for female patients 
was 3.10 (SD = 2.56; 1st Qu. = 1; median = 2; 3rd Qu. = 5). The mean DT score for male 
partners was 3.09 (SD = 2.34; 1st Qu. = 1; median = 3; 3rd Qu. = 5), while the mean DT 
score for female partners was 4.37 (SD = 2.78; 1st Qu. = 2; median = 5; 3rd Qu. = 7). 
A positive correlation of r = 0.5 (n = 208) was demonstrated between patient and 
partner DT scores.  
Clinically significant distress  
The following section quantifies and describes our sample of matched patient-
partner dyads according to individual distress scores. Clinically significant or non-
significant distress was determined according to whether participants DT scores fell above 
or below predefined case rules. According to the case rule recommended for patients by the 
National Comprehensive Cancer Network (NCCN), DT scores of 4 and above (3/4) 
indicate clinically significant emotional distress. In our sample, 33% (71) of patients 
reported scores within a clinically significant range. Using the case rule 4/5 for partners, 
41.2% (89) of the partners in our sample reported DT scores within a clinically significant 
range. 
Table 2 shows the frequency distribution of distress scores for patients and partners.  
(Table 2) 
Association of distress and selected illness-specific variables in patients and partners 
 Type of cancer: With respect to psychological distress (DT) the analysis of variance 
showed no significant difference between types of cancer in patients (F = 1.39; df = 9; p = 
0.18) nor in partners (F = 1.19; df = 9; p = 0.29). 
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Treatment Status: Findings demonstrate a highly significant difference between treatment 
statuses in patients (F = 4.57; df = 6; p < 0.00) as well as in partners (df = 6; F = 4.50; p < 
0.00). Post-hoc analyses (Fisher’s “Least Significant Difference”, Bonferroni corrected) 
and visual examination gave evidence that levels of distress in specific treatment phases 
were described differently by patients and partners. 
Time elapsed since last diagnosis: In patients the correlation of distress and time elapsed 
since last diagnosis (in months) was r = -0.13 while the correlation in partners was r = -
0.02. 
Association of distress and subjective somatic well-being in patients and partners:  
In patients subjective somatic well-being showed moderate association with distress (r 
= 0.58) while in partners the association of distress and patients`subjective somatic 
well-being was lower (r = 0.37). 
Association of distress and relationship length in patients and partners 
Length of relationship: with respect to psychological distress (DT) the correlation 
showed no significant association in patients nor in partners (patients: r = -0.01; 
partners: r = -0.04).  
Group classification according to distress (DT) scores 
Figure 1 shows the scatter plot for dyad distress scores. Each data point in the figure 
represents a patient-partner dyad. The scatter plot is divided into four quadrants according 
to the case rules for clinically significant distress among patients or partners discussed 
above. Dyads are assigned to one of the four quadrants according to the pattern of distress 
within the dyad (patient low-partner low; patient low-partner high; patient high-partner 
low; patient high-partner high). These quadrants are used differentiate between dyads 
containing two distressed individuals (patient hi-partner hi), dyads containing only one 
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distressed individual (either patient or partner) (patient lo-partner hi; patient hi-partner lo), 
and dyads in which neither individual reported clinically significant levels of distress 
(patient lo-partner lo). 
 Quadrant 1 (patient lo-partner lo; n=101 dyads, or 48.5% of the sample) contains 
patient-partner dyads in which clinically significant levels of emotional distress were not 
reported at all. Quadrant 2 (patient lo-partner hi; n=37 dyads, or 17.8% of the sample) 
contains dyads in which only one individual – the partner – reported clinically significant 
distress (5 and above); the patients in this quadrant scored below the current NCCN cut-off 
score. Quadrant 3 (patient hi-partner lo; n=21 dyads, or 10.1% of the sample) contains 
dyads in which only one individual – the patient – reported clinically significant distress; 
the partners in this quadrant reported low distress (4 or below). Quadrant 4 (patient hi-
partner hi; n=49 dyads, or 23.6% of the sample) contains dyads in which both patients and 
their partners reported clinically significant levels of distress. 
 The DT scores suggest that 51.4% (n=107 dyads) of the matched patient-partner 
dyads included at least one individual suffering from significant levels of emotional 
distress (patient hi-partner hi; patient hi-partner lo; patient lo-partner hi). Table 3 
summarizes the findings.  
Examining the quadrants according to gender and role (patient vs. partner) 
The number of men and women observed in each of the four quadrants differed 
significantly from what would be expected – in other words, female and male participants 
are not equally distributed among the four quadrants. This variation is evident for all four 
groups with respect to patients (χ2 = 11.47, df = 3, p < 0.00) and their partners (χ2 = 11.45, 
df = 3, p < 0.00).  
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Dyads composed of female patients and male partners are overrepresented in the 
quadrant of non-distressed couples (Quadrant 1; patient lo-partner lo) and in the quadrant in 
which clinically significant distress was solely reported by patients (Quadrant 3; patient hi-
partner lo). Dyads composed of male patients and female partners, by contrast, are 
overrepresented in the quadrant of mutually distressed couples (Quadrant 4; patient hi-
partner hi) and in the quadrant in which clinically significant distress was solely reported 
by partners (Quadrant 2; patient lo-partner hi).  
 
 
DISCUSSION 
 
In the present investigation, we examined responses to the DT among a 
heterogeneous sample of cancer patients and their matched partners. Our sample was 
unique in that it included both male and female patients and partners, as well as patients 
suffering from different types of cancer and in different stages of treatment.  
Our investigation revealed that 34.2% of male patients and 31.9% of female 
patients reported distress levels above the 3/4 cut-off. Clinically significant distress levels 
measured among partners demonstrated greater gender differences: among male partners, 
29.1% reported distress levels of four and above (4/5); by contrast, a remarkable 50.5% of 
female partners reported distress levels of four and above (4/5). Overall, male patients, 
female patients, and male partners exhibited very similar ranges of distress, while female 
partners exhibited much higher distress. Some aspects of this result serve to verify previous 
findings (e.g., female partners suffer the highest levels of distress; male patients have 
higher distress scores than male partners) [15,28]. However, the suggestion that women 
have a greater overall risk of suffering from distress, as stated in our hypotheses, was not 
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upheld by our findings. Thus, our sample did not confirm Hagedoorn’s statement [28] that 
individual levels of distress are determined more by gender than by patient-partner role.  
The reasons for the remarkably high number of distressed female partners, and the 
sources of their distress, remain unexplained. To achieve a better understanding, additional 
– possibly - prospective research is needed. 
Looking at distress in terms of dyads, in 51.4% of the couples in our sample one 
(whether patient or partner) or both individuals reported clinically significant distress, 
while in the remaining 48.5% of couples neither individual reported clinically significant 
distress levels measured according to the DT. The proportion of dyads in which solely 
patients reported distress was smallest (10.1%) while the number of couples in which both 
patients and their partners reported clinically significant levels of distress was greater 
(23.6%); in a considerable number of dyads (17.8%), solely partners exhibited significant 
levels of distress.  
As previous research suggests, in couples consisting of male patients and female 
partners, women are at higher risk for clinical distress. In addition, however, the present 
investigation showed that the male patient-female partner couples were also more likely to 
demonstrate significant distress in both partners. By contrast, couples including a female 
patient and a male partner were more likely to demonstrate a pattern of patient-only 
distress, or no distress for either partner. From a general systems perspective, one could say 
that female patients are more likely to suffer alone, while male patients more often 
experience shared suffering. This is consistent with the suggestion offered by Benyamini 
[35] that “it may be adaptive for women, as the traditional family caregivers, to be 
responsive to all surrounding events and to any disruptive health problem” (p. 362). Similar 
statements and explanations can be found in Hagedoorn (who cites identity-relevant stress) 
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[36] and Baider (who identifies role expectations and sense of self as factors) [37]. The 
conclusion that women’s report of distress is simply related (via empathy and concern) to 
their partners’ distress is not yet fully supported. One partners’ distress may be related to a 
variety of factors that arise in a secondary way from the experience of cancer. Considering 
the complexity of the matter it remains most probable that no explanation can stand on its 
own. It is important to further investigate the nature of the distress experienced within the 
couple experiencing cancer, and to examine aspects of gender, role, and the systemic 
interaction among factors that appear to bear on the experience of distress.   
Contributors to patient, partner and couple distress are numerous and idiosyncratic. 
In oncology patients’ and families’ psychological health is often closely related to—and 
sometimes determined by— diagnosis (prognosis, treatment possibilities), course of the 
illness (progress or regression), treatment factors (successes or failures) [38,39], and 
familial, social, or professional strains that may arise coincidental with or in consequence 
of the illness [40]. Distress in the present sample was related to treatment status and 
patients` subjective physical well-being but not to cancer type or time elapsed since last 
diagnosis. Furthermore, patients and partners reported differing perceptions of the relative 
difficulty of particular phases of the illness. This finding corresponds to results described in 
the literature [41] and illustrates once more the complexity of the dyadic-systemic and 
idiosyncratic dimensions of the partnership.  
Our findings are of special interest for the clinician: the study revealed that 
male patient-female partner couples are overrepresented in the high risk group (high 
patient – high partner distress) meaning that clinicians might be e attentive to this 
group of couples. As well, couples with a patient with low subjective physical well-
being are more likely to appear in the high risk group. Treatment status is relevant 
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for the experience of distress; however differently in patients and partners. Therefore 
it does not seam to be a consistent indicator for high risk couples. Screening both 
patients and their partners could lead to early detection of potential risk situations and 
timely psychosocial referral. In addition to that future studies should examine in more 
detail the characteristics of the different groups for a better understanding and 
detection of high risk couples.  
Using the DT to screen patients’ and partners may represent one part of a response 
to the legitimate question of how to practically incorporate family members and family 
distress into cancer care programs [4,16,42-46]. When planning such programs it is 
important to note that significant numbers of patients and their family members deny their 
illness-related burdens, and fail either to address their psychological strains or to take 
advantage of supportive resources made available to them, out of fear of being stigmatized 
[47]. Therefore, whether and why selected patients and family members actually consent to 
or ask for psycho-oncological support is an essential issue, one that researchers have only 
recently begun to address [48-50].  
Limitations  
It is important to remember that DT scores can only serve as a tool to assist 
clinicians and should never be considered absolute. It is always possible that short self-
report measures are subject to bias. They are meant to provide clinicians’ with an indication 
that will assist their own estimation. Scores may reflect transitory conditions.  
Two strengths of our investigation were our relatively large sample size and our 
examination of matched patient-partner pairs according to DT scores – representing the 
first time this has been done, to the best of our knowledge. However, a longitudinal design 
would have been more suited to analyzing within couple effects than the cross-sectional 
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design that was used. This places limitations on the interpretation of our results. We cannot 
report on transmission of distress in couples nor on gender differences in transmitting 
distress. These aspects can only be answered by longitudinal prospective studies. Our study 
and its design do not allow for an understanding of the dynamic patterns in the partner 
relationship nor of the direction of changes over time.  
Future studies examining the dynamics of within-couple processes over time might 
seek to provide a better understanding of the variables influencing distress among couples. 
Also relevant to individual experiences of distress, but not accounted for in our analyses, 
are personal histories of cancer. The present report relied on the recommendations of a 
single validation study suggesting cutoff 4/5 for family members. Further evidence of the 
validity of the DT, and the validity of each of the two cutoff scores currently reported in the 
literature, is needed.  
While our sample showed a wide range of distress scores, the overall mean distress level 
was not high. Therefore, the generalizability of our results to a highly distressed population 
remains to be shown. The investigation is also limited by the absence of a comparison 
group, which is not experiencing a significant illness. The moderate rate of participation 
reported here also impacts the generalization of its findings.  
Our lower than expected participation rate may be attributed, in part, to the factors 
described below. First, questionnaires reached family members in an indirect manner – 
whether they received the questionnaire or not depended on patients’ willingness to pass it 
on to them. Further, patients were mailed the questionnaires but were not approached in 
person or by telephone by medical or research staff. The questionnaire was not 
accompanied by a pre-notification letter, nor was reminder letters sent. Completing the 
questionnaire was a time-consuming process that required participants to reflect on 
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potentially difficult emotions. Patients may also have been reluctant to reveal personal 
experiences for a research study. A review of published non-response bias studies 
documented that a moderate or low response rate does not necessarily imply high bias [51].  
Unfortunately, the study design did not allow us to compare data of study acceptors and 
refusers. Reasons provided by refusers suggest that those persons may have experienced 
distress, but no analysis or conclusions can be drawn from refuser data. 
Conclusions  
According to the results of our current analyses, a considerable proportion of the 
dyads we examined were affected by significant distress levels occurring in one or both 
partners. The different patterns of distress that we identified suggest varying risks for 
psychosocial strain occurring among different couples. We were also able to show that 
couples’ distress patterns varied with their gender and role (patient vs. partner) 
composition. This finding however does not indicate that gender is a causal factor. 
This question should be addressed in future studies in more detail. From a clinical 
point of view opting to screen both patients and their significant others using the DT is one 
way of responding to the growing call internationally to include families of cancer patients 
in cancer care programs. Screening patients’ partners in addition to patients themselves 
may enable earlier identification of risk settings and timely psychosocial referral. The 
support offered to either individual within such dyads should account for their role- and 
gender-specific needs. 
Future research could seek to further clarify the findings as regards gender, role, 
and distress levels also taking interactional aspects into account. A necessary amplification 
of these analyses must be the inclusion of further sociodemographic and illness-specific 
variables and their influence on distress. In addition, research in the field might profit from 
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studies that investigate the practicability of psychosocial screening programs that include 
significant others.  
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Table 1 
Sociodemographic- and disease-related characteristics of the sample (N=224 couples)  
 Partners Patients 
 n % n % 
Gender 
 Female 126 56.2 98 43.7 
 Male 98 43.7 126 56.2 
Age (median + range) 59.5 (23-85)  60.0 (24-87) 
Education 
 Obligatory School 20 8.9 21 9.3 
 Apprenticeship 114 50.9 111 49.6 
 High School 12 5.4 12 5.4 
 Technical College 32 14.3 39 17.6 
 University Degree 28 12.5 25 11.3 
 Other 12 5.4 14 6.3 
Civil status  
 Married   190 84.8 
 Unmarried   34 15.2 
Years of partnership (median + range)   30 (1-60) 
Habitation 
 Cohabiting   210 93.8 
 Not cohabiting   14 6.3 
Household income/month (in Swiss Francs) 
 <3,000   14 6.3 
 3,000-5,999   69 31.4 
 6,000-9,999   88 39.3 
 >10,000   49 21.9 
Cancer Site (multiple responses possible) 
 Lymphoma   50 22.3 
 Melanoma   38 17.0 
 Intestinal   32 14.3 
 Breast   22 9.8 
 Lung    21 9.4 
 Leukemia   17 7.6 
 Myeloma   14 6.3 
 Liver   8 3.6 
 Testicular   7 3.1 
 Other   52 23.0 
Applied Cancer Treatment (multiple responses possible) 
 Chemotherapy   171 76.3 
 Surgery   121 54.0 
 Radiotherapy   89 39.7 
 Other   64 28.4 
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Number of treatments undergone    
 0   5 5.5 
 1   81 36.2 
 2   70 31.3 
 3   53 23.7 
 4   15 6.7 
Treatment Status  
 In Treatment (First Diagn.)   34 15.2 
 Off Treatment (First Diagn.)   71 31.7 
 In Treatment (Relapse/New Diagn.)   43 19.2
 Off Treatment (Relapse/New Diagn.)   26 11.6 
 Cured   12 5.4 
 Palliative Stage   7 3.1 
 Status Unknown to Patient   31 13.8 
Time elapsed since diagnosis (median + range, in months) 18 (1-265) 
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Table 2 
Frequency distribution of the DT scores of family members and patients for male and 
female participants separately 
    Patients    Partners 
      male      female    male      female 
DT No.   %  No.    %  No.    %  No.    % 
0 14 12.0  12 13.4  12 12.9    9   7.8 
1 21 17.9  14 15.6  16 17.2  16 13.9 
2 24 20.5  22 24.5  17 18.3    9   7.8 
3 18 15.4  13 14.5  14 15.1  12 10.4 
4 2   1.7    5   5.6    7   7.5  11   9.6 
5 13 11.1    8   8.9  10 10.8  20 17.4 
6 10   8.5    4   4.4    7   7.5    8   7.0 
7 7   6.0    2   2.2    6   6.5  11   9.6 
8 4   3.4    7   7.5    3   3.2  12 10.4 
9 3   2.6    2   2.2    1   1.1    3   2.6 
10 1   0.9    1   1.1    0   0    4   3.5 
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Table 3 
 
Gender-related Frequency of Dyads with Specific Distress Patterns 
   
Qdr.  Distress  n   %  Type of Dyad     n  %  
No       Pat – Par               within Qdr 
 
 1:  lo-lo  101  48.5  Female patient-dyads  53 52.4 
       Male patient-dyads  48 47.5 
 
2:  lo-hi   37 17.8  Female patient-dyads  11 29.7 
       Male patient-dyads  26 70.2 
           
3:  hi-lo   21 10.1  Female patient-dyads  13 61.9 
       Male patient-dyads  8 38.1 
 
4:  hi-hi   49 23.6  Female patient-dyads  15 30.6 
       Male patient-dyads  34 69.3 
 
